Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beyond AirXAIR -18.10%23 3-1 Month Momentum % is -38.65% as of Aug. 30, 2026. GuruFocus rates XAIR with a GF Score™ of 23/100 and a GF Value™ of $401.70 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Beyond Air ranks worse than 91.89% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-30), Beyond Air's 3-1 Month Momentum % is -38.65%.
The industry rank for Beyond Air's 3-1 Month Momentum % or its related term are showing as below:
XAIR's 3-1 Month Momentum % is ranked worse than 91.89% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: -7.58
vs XAIR: -38.65
Beyond Air (NAS:XAIR) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Beyond Air 3-1 Month Momentum % Related Terms
XAIR vs POAS, RMSL, LUDG: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Beyond Air's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Beyond Air's 3-1 Month Momentum % falls into.
Beyond Air (NAS:XAIR) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (XAIR) has a 3-1 Month Momentum % of -38.65% as of Aug. 30, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Beyond Air and its competitors. According to the industry distribution chart, Beyond Air ranks #782 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 91.9%.
Is Beyond Air's 3-1 Month Momentum % too high?
Beyond Air's current 3-1 Month Momentum % is -38.65%. Based on the distribution chart, Beyond Air ranks #782 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beyond Air has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's 3-1 Month Momentum % compare to POAS and RMSL?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #782 out of 851 companies for 3-1 Month Momentum %. This places Beyond Air in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Beyond Air and its competitors. Beyond Air's current 3-1 Month Momentum % is -38.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Based on GuruFocus' analysis, Beyond Air (XAIR) is currently considered Possible Value Trap. The stock's GF Value™ is $401.70, compared to a current price of $4.44 — trading 98.9% below its estimated fair value. The current 3-1 Month Momentum % is -38.65%. Beyond Air's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Beyond Air (XAIR), the current 3-1 Month Momentum % is -38.65% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beyond Air (XAIR) Overvalued in 2026?
Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued.
The current stock price of $4.44 is trading 98.9% below its estimated GF Value™ of $401.70.
GuruFocus considers Beyond Air to be Possible Value Trap.
Key valuation signals for XAIR:
3-1 Month Momentum %: -38.65%
GF Value™: $401.70 vs. price of $4.44 (98.9% below fair value)
No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
23GF Score
Get the complete analysis for XAIR
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAIR has been successfully added to your 
